Zhou, Jing-Shuang
Chen, Jian-Hong
Tang, Fei-Fei
Ou, Jian-Ping
Tao, Xin
Cai, Liu-Hong
Article History
Received: 11 February 2023
Accepted: 11 August 2023
First Online: 23 August 2023
Declarations
:
: The authors declare no competing interests.
: The study was approved by the Ethics Committee Review Board of The Third Affiliated Hospital, Sun Yat-sen University (No: [2021]02-246-01). All procedures performed in this study were in accordance with the Ethical Review of Biomedical Research Involving People (2016) by the National Health and Family Planning Commission, the Good Clinical Practice Guideline of Pharmaceutical Products (2020), Provisions for Medical Device Classification (2004), Guidelines for Ethical Review of Drug Clinical Trials (2010), (2007) by the National Food and Medical Products Administration, Administrative Measures for Clinical Research on Stem Cells (Trial) (2015) by the National Health and Family Planning Commission and the National Food and Medical Products Administration, as well as Declaration of Helsinki by WMA, International Ethical Guidelines for Human Biomedical Research Involving Human Subjects by ICH-GCP and CIOMS. All methods were carried out in accordance with relevant guidelines and regulations. All participants provided written informed consent to participate in this study.
: Not applicable.
: No potential conflict of interest was reported by the authors.